Role of microglia-neuron interactions in diabetic encephalopathy

Yuan Liu1, Mingchao Li1, Zuo Zhang2

  • 1Department of Pharmacy, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China; National Drug Clinical Trial Institution, The Second Affiliated Hospital, Army Medical University, Chongqing, 400037, China.

Ageing Research Reviews
|December 17, 2017
PubMed

Insights

Microglia, the brain's immune cells, are crucial in diabetic encephalopathy. Their activation, influenced by neuronal signals and metabolic changes, presents a potential therapeutic target for this condition.

Area of Science:

  • Neuroscience
  • Immunology
  • Metabolic Disorders

Background:

  • Microglia are the primary immune cells in the central nervous system, acting as the first line of defense.
  • Microglial activity and energy metabolism are closely linked and crucial for neuronal health.
  • Microglia-neuron interactions are implicated in the pathogenesis of diabetic encephalopathy.

Purpose of the Study:

  • To explore the role of microglia and their interactions with neurons in diabetic encephalopathy.
  • To identify potential therapeutic targets for modulating microglial activity in this condition.

Main Methods:

  • The study reviews the expression of energy substrate transporters in microglia.
  • It discusses the regulation of microglial activation by various factors, including neuronal signals and inflammatory mediators.
  • The role of specific signaling pathways (e.g., CX3CL1, p38 MAPK) in microglia-neuron interactions within diabetic encephalopathy is examined.

Main Results:

  • Microglia utilize glucose, fatty acids, and glutamine, with consumption varying by activity level.
  • Hyperactive neurons in hyperglycemia/hyperlipidemia release factors that activate microglia.
  • Microglial activation is modulated by inflammatory factors, cellular signaling pathways, and pattern recognition receptors.

Conclusions:

  • Microglia-neuron interactions are significant in diabetic encephalopathy.
  • Targeting microglial activation pathways offers a promising therapeutic strategy for managing diabetic encephalopathy.